BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 28815891)

  • 1. Cystic kidneys in fetal Walker-Warburg syndrome with POMT2 mutation: Intrafamilial phenotypic variability in four siblings and review of literature.
    Nabhan MM; ElKhateeb N; Braun DA; Eun S; Saleem SN; YungGee H; Hildebrandt F; Soliman NA
    Am J Med Genet A; 2017 Oct; 173(10):2697-2702. PubMed ID: 28815891
    [TBL] [Abstract][Full Text] [Related]  

  • 2. POMT2 mutations cause alpha-dystroglycan hypoglycosylation and Walker-Warburg syndrome.
    van Reeuwijk J; Janssen M; van den Elzen C; Beltran-Valero de Bernabé D; Sabatelli P; Merlini L; Boon M; Scheffer H; Brockington M; Muntoni F; Huynen MA; Verrips A; Walsh CA; Barth PG; Brunner HG; van Bokhoven H
    J Med Genet; 2005 Dec; 42(12):907-12. PubMed ID: 15894594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fetal Presentation of Walker-Warburg Syndrome with Compound Heterozygous
    Zago S; Silvestri E; Arcangeli T; Calisesi M; Romeo C; Parmeggiani G; Parrini E; Cetica V; Guerrini R; Palicelli A; Bonasoni MP
    Fetal Pediatr Pathol; 2023 Apr; 42(2):334-341. PubMed ID: 36048137
    [No Abstract]   [Full Text] [Related]  

  • 4. 160 kb deletion in ISPD unmasking a recessive mutation in a patient with Walker-Warburg syndrome.
    Czeschik JC; Hehr U; Hartmann B; Lüdecke HJ; Rosenbaum T; Schweiger B; Wieczorek D
    Eur J Med Genet; 2013 Dec; 56(12):689-94. PubMed ID: 24120487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Noncompaction cardiomyopathy in an infant with Walker-Warburg syndrome.
    Abdullah S; Hawkins C; Wilson G; Yoon G; Mertens L; Carter MT; Guerin A
    Am J Med Genet A; 2017 Nov; 173(11):3082-3086. PubMed ID: 28980384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel cardiovascular findings in association with a POMT2 mutation: three siblings with α-dystroglycanopathy.
    Martinez HR; Craigen WJ; Ummat M; Adesina AM; Lotze TE; Jefferies JL
    Eur J Hum Genet; 2014 Apr; 22(4):486-91. PubMed ID: 24002165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical long-time course, novel mutations and genotype-phenotype correlation in a cohort of 27 families with POMT1-related disorders.
    Geis T; Rödl T; Topaloğlu H; Balci-Hayta B; Hinreiner S; Müller-Felber W; Schoser B; Mehraein Y; Hübner A; Zirn B; Hoopmann M; Reutter H; Mowat D; Schuierer G; Schara U; Hehr U; Kölbel H
    Orphanet J Rare Dis; 2019 Jul; 14(1):179. PubMed ID: 31311558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutations in the O-mannosyltransferase gene POMT1 give rise to the severe neuronal migration disorder Walker-Warburg syndrome.
    Beltrán-Valero de Bernabé D; Currier S; Steinbrecher A; Celli J; van Beusekom E; van der Zwaag B; Kayserili H; Merlini L; Chitayat D; Dobyns WB; Cormand B; Lehesjoki AE; Cruces J; Voit T; Walsh CA; van Bokhoven H; Brunner HG
    Am J Hum Genet; 2002 Nov; 71(5):1033-43. PubMed ID: 12369018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroimaging manifestations and genetic heterogeneity of Walker-Warburg syndrome in Saudi patients.
    Alharbi S; Alhashem A; Alkuraya F; Kashlan F; Tlili-Graiess K
    Brain Dev; 2021 Mar; 43(3):380-388. PubMed ID: 33199158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A case of Walker-Warburg syndrome resulting from a homozygous POMT1 mutation.
    Yis U; Uyanik G; Kurul S; Dirik E; Ozer E; Gross C; Hehr U
    Eur J Paediatr Neurol; 2007 Jan; 11(1):46-9. PubMed ID: 17161965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Refining genotype phenotype correlations in muscular dystrophies with defective glycosylation of dystroglycan.
    Godfrey C; Clement E; Mein R; Brockington M; Smith J; Talim B; Straub V; Robb S; Quinlivan R; Feng L; Jimenez-Mallebrera C; Mercuri E; Manzur AY; Kinali M; Torelli S; Brown SC; Sewry CA; Bushby K; Topaloglu H; North K; Abbs S; Muntoni F
    Brain; 2007 Oct; 130(Pt 10):2725-35. PubMed ID: 17878207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Skeletal muscle MRI of the lower limbs in congenital muscular dystrophy patients with novel POMT1 and POMT2 mutations.
    Hafner P; Bonati U; Fischmann A; Schneider J; Frank S; Morris-Rosendahl DJ; Dumea A; Heinimann K; Fischer D
    Neuromuscul Disord; 2014 Apr; 24(4):321-4. PubMed ID: 24556424
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Walker-Warburg syndrome.
    Vajsar J; Schachter H
    Orphanet J Rare Dis; 2006 Aug; 1():29. PubMed ID: 16887026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Compound heterozygous POMT1 mutations in a Chinese family with autosomal recessive muscular dystrophy-dystroglycanopathy C1.
    Hu P; Wu S; Yuan L; Lin Q; Zheng W; Xia H; Xu H; Guan L; Deng H
    J Cell Mol Med; 2017 Jul; 21(7):1388-1393. PubMed ID: 28157257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Missense mutations in β-1,3-N-acetylglucosaminyltransferase 1 (B3GNT1) cause Walker-Warburg syndrome.
    Buysse K; Riemersma M; Powell G; van Reeuwijk J; Chitayat D; Roscioli T; Kamsteeg EJ; van den Elzen C; van Beusekom E; Blaser S; Babul-Hirji R; Halliday W; Wright GJ; Stemple DL; Lin YY; Lefeber DJ; van Bokhoven H
    Hum Mol Genet; 2013 May; 22(9):1746-54. PubMed ID: 23359570
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutations in ISPD cause Walker-Warburg syndrome and defective glycosylation of α-dystroglycan.
    Roscioli T; Kamsteeg EJ; Buysse K; Maystadt I; van Reeuwijk J; van den Elzen C; van Beusekom E; Riemersma M; Pfundt R; Vissers LE; Schraders M; Altunoglu U; Buckley MF; Brunner HG; Grisart B; Zhou H; Veltman JA; Gilissen C; Mancini GM; Delrée P; Willemsen MA; Ramadža DP; Chitayat D; Bennett C; Sheridan E; Peeters EA; Tan-Sindhunata GM; de Die-Smulders CE; Devriendt K; Kayserili H; El-Hashash OA; Stemple DL; Lefeber DJ; Lin YY; van Bokhoven H
    Nat Genet; 2012 May; 44(5):581-5. PubMed ID: 22522421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutations of the POMT1 gene found in patients with Walker-Warburg syndrome lead to a defect of protein O-mannosylation.
    Akasaka-Manya K; Manya H; Endo T
    Biochem Biophys Res Commun; 2004 Dec; 325(1):75-9. PubMed ID: 15522202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fukutin mutations in non-Japanese patients with congenital muscular dystrophy: less severe mutations predominate in patients with a non-Walker-Warburg phenotype.
    Yis U; Uyanik G; Heck PB; Smitka M; Nobel H; Ebinger F; Dirik E; Feng L; Kurul SH; Brocke K; Unalp A; Özer E; Cakmakci H; Sewry C; Cirak S; Muntoni F; Hehr U; Morris-Rosendahl DJ
    Neuromuscul Disord; 2011 Jan; 21(1):20-30. PubMed ID: 20961758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New POMT2 mutations causing congenital muscular dystrophy: identification of a founder mutation.
    Yanagisawa A; Bouchet C; Van den Bergh PY; Cuisset JM; Viollet L; Leturcq F; Romero NB; Quijano-Roy S; Fardeau M; Seta N; Guicheney P
    Neurology; 2007 Sep; 69(12):1254-60. PubMed ID: 17634419
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel missense mutation in POMT1 modulates the severe congenital muscular dystrophy phenotype associated with POMT1 nonsense mutations.
    Wallace SE; Conta JH; Winder TL; Willer T; Eskuri JM; Haas R; Patterson K; Campbell KP; Moore SA; Gospe SM
    Neuromuscul Disord; 2014 Apr; 24(4):312-20. PubMed ID: 24491487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.